Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/190002
Title: | Type 2 diabetes mellitus and COVID-19: a narrative review |
Author: | Rey Reñones, Cristina Martinez Torres, Sara Martín Luján, Francisco M Pericas, Carles Redondo, Ana Vilaplana Carnerero, Carles Domínguez García, Àngela Grau, Maria |
Keywords: | Diabetis COVID-19 Epidemiologia Diabetes COVID-19 Epidemiology |
Issue Date: | 26-Aug-2022 |
Publisher: | MDPI |
Abstract: | Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients. |
Note: | Reproducció del document publicat a: |
It is part of: | Biomedicines, 2022, vol. 10, p. 2089 |
URI: | http://hdl.handle.net/2445/190002 |
ISSN: | 2227-9059 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
724610.pdf | 875.04 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License